Bruce Robinson

Professor, MD W.Aust., DTM&H Liv., FRACP, FRCP

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 8837 Citations
  • 48 h-Index
1992 …2022
If you made any changes in Pure these will be visible here soon.

Personal profile

Roles and responsibilities

Consultant Physician, Respiratory medicine, Sir Charles Gardner Hospital
Research Scientist, Tumour Immunology Group, University of Western Australia. Regularly speaking at major international meetings & has made numerous media appearances relating to science.
Lectures, seminars and clinical teaching to 3rd-6th year medical students
Co-founder and Director of the National Centre for Asbestos Related Diseases [www.ncard.org], Chairs the State Health Research Advisory Council [www.shrac.health.wa.gov.au]
Co-founder and director of the International Skills and Training Institute in Health [www.istih.org], a philanthropic organization which provides services and training in disaster situations within the Asian region.

Teaching overview

35 years experience in teaching medical students, including new programs in communication skills [‘how to break bad news to patients'] and in medical research through lecturing, seminars and clinical teaching. He has also initiated teaching weekends and medical teacher development days. Winner of 3 UWA Medical School Teacher-of-the-Year awards.

Research

Co-leader of a large research team studying cancer immunology and asbestos diseases. The team have made many discoveries, including the first blood test for mesothelioma and have conducted many world-first treatments, including Australia's first cancer gene therapy trial.

Languages

Fluent:
English, Indonesian
Basic understanding:
Italian, French

Keywords

  • Cancer
  • Immunology
  • Respiratory medicine

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 30 Similar Profiles
Mesothelioma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Asbestos Medicine & Life Sciences
Tumors Chemical Compounds
Immunotherapy Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Genes Chemical Compounds
Cross-Priming Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1996 2022

Research Output 1992 2018

22 Citations

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

The Cancer Genome Atlas Network, 5 Apr 2018, In : Cell. 173, 2, p. 291-304.e6

Research output: Contribution to journalArticle

Open Access
Tumors
Tissue
Histology
Methylation
Oncology
2 Citations

Clinical guidance for radioiodine refractory differentiated thyroid cancer

Gild, M. L., Topliss, D. J., Learoyd, D., Parnis, F., Tie, J., Hughes, B., Walsh, J. P., McLeod, D. S. A., Clifton-Bligh, R. J. & Robinson, B. G., 1 Apr 2018, In : Clinical Endocrinology. 88, 4, p. 529-537 9 p.

Research output: Contribution to journalReview article

Thyroid Neoplasms
Therapeutics
Phase III Clinical Trials
Disease-Free Survival
Phosphotransferases

Combination immune checkpoint blockade as an effective therapy for mesothelioma

Fear, V., Tilsed, C. M., Chee, H. E. J., Forbes, C., Casey, T., Solin, J., Lansley, S., Lesterhuis, W., Dick, I., Nowak, A., Robinson, B., Lake, R. & Fisher, S., 30 Jul 2018, In : Oncolmmunology. 14 p., e1494111

Research output: Contribution to journalArticle

Open Access
Mesothelioma
Neoplasms
Therapeutics
Asbestos
Regulatory T-Lymphocytes
9 Citations

Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas

The Cancer Genome Atlas Research Network, 9 Apr 2018, In : Cancer Cell. 33, 4, p. 721-735.e8

Research output: Contribution to journalArticle

Open Access
Adenocarcinoma
Neoplasms
Genome
Chromosomal Instability
Rectum

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

Tsao, A. S. , Lindwasser, O. W. , Adjei, A. A. , Adusumilli, P. S. , Beyers, M. L. , Blumenthal, G. M. , Bueno, R. , Burt, B. M. , Carbone, M. , Dahlberg, S. E. , de Perrot, M. , Fennell, D. A. , Friedberg, J. , Gill, R. R. , Gomez, D. R. , Harpole, D. H. , Hassan, R. , Hesdorffer, M. , Hirsch, F. R. , Hmeljak, J. & 21 others Kindler, H. L., Korn, E. L., Liu, G., Mansfield, A. S., Nowak, A. K., Pass, H. I., Peikert, T., Rimner, A., Robinson, B. W. S., Rosenzweig, K. E., Rusch, V. W., Salgia, R., Sepesi, B., Simone, C. B., Sridhara, R., Szlosarek, P., Taioli, E., Tsao, M. S., Yang, H., Zauderer, M. G. & Malik, S. M., 1 Nov 2018, In : Journal of Thoracic Oncology. 13, 11, p. 1655-1667 13 p.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Mesothelioma
Thorax
Clinical Trials
Research